Quarterly report pursuant to Section 13 or 15(d)

Balance Sheets

v3.21.1
Balance Sheets - USD ($)
Mar. 31, 2021
Dec. 31, 2020
Current assets    
Cash $ 30,404,951 $ 28,660,375
Total current assets 30,404,951 28,660,375
Acquired patents, net 15,324 16,227
Total assets 30,420,275 28,676,602
Current liabilities    
Accounts payable & accrued interest 609,274 710,971
Unreimbursed expenses 63,848 59,367
Advance from related party/shareholder 275,154
Total current liabilities 673,122 1,045,492
Total liabilities 673,122 1,045,492
Stockholders' equity    
Common stock, $0.001 par value; 100,000,000 shares authorized; 12,846,897 and 12,703,541 shares issued and outstanding as of March 31, 2021 and December 31, 2020, respectively 12,847 12,704
Additional paid-in capital 59,408,267 56,695,359
Accumulated deficit (29,673,961) (29,076,953)
Total stockholders' equity 29,747,153 27,631,110
Total liabilities and stockholders' equity $ 30,420,275 $ 28,676,602